“Emerging Therapies for Neuroendocrine Tumors: New Perspectives for Oncology Nurses,” is an educational program jointly provided by the Postgraduate Institute for Medicine and the Center of Excellence Media, LLC. The program, offered through June 30, 2016, is directed toward oncology nurses and other cancer care professionals who are involved in the care of patients with neuroendocrine tumors (NETs).
The activity will focus on:
- Describing neuroendocrine tumors by histological classification, categorization of tumor type, and stage
- Administering individualized, evidence-based, systemic therapy for neuroendocrine tumors, particularly with emerging targeted agents
- Supporting patient adherence with therapy, including oral and injectable targeted agents, and encouraging patient self-care
- Formulating effective approaches to the management of disease- and treatment-related symptom clusters in patients with neuroendocrine tumors
- Providing appropriate care and counsel for patients and their families
Faculty for this educational program are:
• Carmen B. Jacobs, BS, RN, OCN, CCRP
Senior Clinical Research Quality Specialist
The University of Texas
MD Anderson Cancer Center
Houston, Texas
• Eileen M. Regan, MSN, NP, OCN
Research Nurse
Center for Gastrointestinal Cancer
Dana-Farber Cancer Institute
Boston, Massachusetts
• Donna Collins Williams, RN, PHN
Oncology Research Nurse
Cancer Clinical Trials Office
Friedenrich Center for Translational Research
Stanford, California
This education activity for 1.1 contact hours is provided by Postgraduate Institute for Medicine. It is designated for 0.4 contact hours of pharmacotherapy credit by Advance Practice Registered Nurses.
Ipsen is supporting this activity with an independent educational grant.
For more information and to register for the Emerging Therapies for Neuroendocrine Tumors activity, click here: http://www.lynxcme.com/index.php?option=com_mcme&view=course&secid=1&courseid=63&Itemid=155.
